Wellness Peptides Are Going Mainstream. The Science Hasn’t Kept Up
TL;DR AI
2 min readKey summary
The Trump administration and FDA plan to ease restrictions on certain wellness peptides made by compounding pharmacies.
The move follows political pressure from Robert F. Kennedy Jr. and others.
Many promoted peptides such as BPC-157, CJC-1295, ipamorelin, and TB-500 are not FDA-approved for human use.
The article says these products have little or no rigorous clinical evidence, widening concerns about safety and effectiveness.
Same topic
